Skip to main content
Clinical Trials/NCT06128746
NCT06128746
Recruiting
Not Applicable

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Spasticity in Children With Hemiplegic Cerebral Palsy/ Hemiplegia Due to Acquired Brain Injury - a Randomized Controlled Trial

The University of Hong Kong1 site in 1 country20 target enrollmentJanuary 13, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
CP (Cerebral Palsy)
Sponsor
The University of Hong Kong
Enrollment
20
Locations
1
Primary Endpoint
The range of motion scores
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This RCT aims to investigate the effect of repetitive transcranial magnatic stimulation (rTMS) in treating children with hemiplegoc cerebral palsy. The study will measure any improvement in spasticity after using contra-lesional inhibitory rTMS follow by intensive limb training.

Participants will attend a 10-day rTMS treatment sessions, follow by intensive training of the impaired limb. They will also undergo MRI scans before and after the treatment to investiagte the underlying neurophysiological mechanisms that lead to changes clinically by using TMS as well as MR-DKI. Researchers will compare the intervention group and the sham group to see if rTMS could result in improvement of participants' spasticity.

Detailed Description

Cerebral palsy is the most common cause of lifelong physical disability in childhood, with an estimated prevalence of 1.5 per 1000 living biths for primary school-aged children. Spasticity is the most common symptoms in children with cerebral palsy, leading to muscle weakness affecting gross motor functions and causing complications such as pain, contracture and subluzation which will lead to inability to perform activity-based training and subsequently lead to further muscle weakness. Standard therapy with regular physiotherapy and occupational therapy are essential but time-consuming and the effects might not last for longer duration. Patients or caregivers decline medications because of side effects drowsiness while other interventions such as intra-thecal baclofen pump, rhizotomy or surgery are invasive. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique that has the ability to modulate excitation of the motor cortex area of the brain. There were past studies suggesting that using contralesional inhibitory rTMS was safe and feasible for patients with paediatric subcortical stroke and seemed to improve hand function in patients with hemiparesis. However, limited studies have been published on the effects of rTMS on improving spasticity in children with cerebral palsy. Hence, the objective of this study is to use low-frequency rTMS to the contra-lesional hemisphere in children with hemiplegic cerebral palsy to investigate if rTMS follow by intensive limb training would improve spasiticity of these children and whether the improvement can be sustained for a longer time. The underlying mechanisms that lead to the changes clinically will also be investigated by TMS and MRI.

Registry
clinicaltrials.gov
Start Date
January 13, 2024
End Date
July 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Winnie Wan Yee Tso (Dr)

Clinical Assistant Professor

The University of Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Patients aged between 7 years and 18 years
  • Diagnosis of cerebral palsy with hemiplegia
  • Upper limb spasticity ≥ 1

Exclusion Criteria

  • Any contra-indications to rTMS
  • Severe spasticity (score of 4 or more in Ashworth scale)
  • Uncontrollable epilepsy
  • History of Botulinum toxin A injection in previous 6 months
  • Upper limb casting in previous 6 months

Outcomes

Primary Outcomes

The range of motion scores

Time Frame: Day 10, 17 of intervention and 2 months post intervention

ROM of thumb adduction, wrist dorsal flexion and extension, and elbow dorsal flexion and extension. Patients' range of motion score will be compared to the normative values

Modified Ashworth Scale

Time Frame: Day 10, 17 of intervention and 2 months post intervention

Clinical measure of spasticity. Scores range from 0 to 4, with a higher score indicate worse in muscle tone

Secondary Outcomes

  • Zancolli scale(Day 10, 17 of intervention and 2 months post intervention)
  • Gross motor function measure(Day 10, 17 of intervention and 2 months post intervention)
  • Pediatric Quality of Life Cerebral Palsy module(Day 10, 17 of intervention and 2 months post intervention)
  • MRI Brain: fMRI and DKI(Day 10, 17 of intervention and 2 months post intervention)
  • Assisting hand assessment(Day 10, 17 of intervention and 2 months post intervention)
  • House functional classification scale(Day 10, 17 of intervention and 2 months post intervention)

Study Sites (1)

Loading locations...

Similar Trials